Literature DB >> 11120198

Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2.

T Miyashita1, S Enosawa, S Suzuki, A Tamura, H Tanaka, H Amemiya, T Matsumura, T Omasa, K Suga, T Aoki, Y Koyanagi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11120198     DOI： 10.1016/s0041-1345(00)01697-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors.

Authors:  Satdarshan P S Monga; Mariah S Hout; Matt J Baun; Amanda Micsenyi; Peggy Muller; Lekha Tummalapalli; Aarati R Ranade; Jian-Hua Luo; Stephen C Strom; Jörg C Gerlach
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

2.  Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia.

Authors:  M A Torres-Vega; R Y Vargas-Jerónimo; A G Montiel-Martínez; R M Muñoz-Fuentes; A Zamorano-Carrillo; A R Pastor; L A Palomares
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

3.  Development of a genetically modified hepatoma cell line with heat-inducible high liver function.

Authors:  Hiroyuki Kitano; Yuki Nagae; Yoshinori Kawabe; Akira Ito; Masamichi Kamihira
Journal:  Cytotechnology       Date:  2021-02-24       Impact factor: 2.040
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.